Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pioglitazone for Hepatic Steatosis in HIV/HCV Co-infection

NCT00742326 is registered in ClinicalTrials.gov with National Institute of Allergy and Infectious Diseases (NIAID) as lead sponsor.

NCT NCT00742326
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00742326 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pioglitazone for Hepatic Steatosis in HIV/HCV Co-infection
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Phase
Phase 4
Overall status
Terminated
Start date
August 31, 2008
Completion date
January 31, 2013
Enrollment
13 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

fatty liver, hepatitis c, hiv, liver disease, steatosis